Evidence from animal studies and human brain imaging shows that chronic alcohol exposure disrupts the endocannabinoid system, and blocking CB1 receptors reduces alcohol consumption, relapse, and dopamine release in reward circuits.
Read this if you are interested in the biological connections between the endocannabinoid system and alcohol dependence.
CB1 blockade reduces alcohol drinking, dopamine release, and relapse in animal models
What the researchers found
This review synthesized evidence showing that the endocannabinoid system plays a central role in alcohol-motivated behavior. Chronic alcohol exposure increases endocannabinoid levels, which in turn downregulates CB1 receptors and uncouples them from their downstream signaling pathways.
In rodent studies, blocking CB1 receptors with rimonabant or genetically deleting them reduced voluntary alcohol drinking, alcohol-triggered dopamine release in the reward center (nucleus accumbens), self-administration of alcohol, and reinstatement/relapse behavior.
PET brain imaging in human alcoholic patients confirmed similar CB1 receptor downregulation across multiple brain regions, suggesting the animal findings translate to humans.
However, rimonabant's psychiatric side effects limit its clinical use. The review highlights two promising alternatives: negative allosteric modulators of CB1 and inhibitors of endocannabinoid breakdown enzymes.
Why it matters
Alcohol use disorder is a massive health problem with limited treatment options. The endocannabinoid system represents a validated therapeutic target, and understanding how it drives alcohol-seeking behavior could lead to new medications, particularly if the psychiatric side effects of direct CB1 blockade can be avoided.
The numbers in context
Chronic alcohol exposure increases endocannabinoid levels in cell culture and rodent models. PET imaging confirms CB1 downregulation in multiple brain regions of human alcoholics. Rimonabant and CB1 genetic deletion reduce alcohol drinking, self-administration, and relapse in rodents.
How the study worked
Narrative review synthesizing preclinical rodent studies, genetic knockout experiments, in vitro cell culture work, and human PET imaging studies examining the relationship between the endocannabinoid system and alcohol-motivated behavior.
What this study cannot tell us
Most evidence comes from animal models that may not fully replicate human alcohol use disorder. Rimonabant's clinical failure limits the direct translatability. The newer approaches (allosteric modulators, enzyme inhibitors) remain in early development.
How to read the evidence
Narrative review synthesizing converging evidence from multiple methodologies (cell culture, animal models, human PET imaging), but no new primary data.
When this study was published
Published in 2016. Research on peripherally restricted CB1 antagonists and allosteric modulators for addiction has progressed since.
The bigger picture
The convergence of animal and human data makes the endocannabinoid system one of the more validated targets for alcohol use disorder treatment. The challenge is developing drugs that preserve the therapeutic effects of CB1 modulation while avoiding the depression and anxiety that plagued rimonabant.
Questions still open
- Could negative allosteric modulators of CB1 treat alcohol use disorder without psychiatric side effects? Does the endocannabinoid disruption caused by alcohol contribute to the high rates of cannabis co-use among people with alcohol problems?
Common questions
How does the endocannabinoid system relate to alcohol addiction?
Why not just use a CB1 blocker to treat alcoholism?
Read the original research
Roles for the endocannabinoid system in ethanol-motivated behavior.
Progress in neuro-psychopharmacology & biological psychiatry, 65, 330-9
Citation
Henderson-Redmond, Angela N; Guindon, Josée; Morgan, Daniel J. (2016). Roles for the endocannabinoid system in ethanol-motivated behavior.. Progress in neuro-psychopharmacology & biological psychiatry, 65, 330-9. https://doi.org/10.1016/j.pnpbp.2015.06.011
Explore the wider topic
- Physical vs Psychological Cannabis Dependence: What Science Actually Shows
- The Gap Between Cannabis Perception and Science: Why What We Believe Outpaces What We Know
- Cannabis Use Disorder: Am I Addicted? Self-Assessment Guide
- Cross-Addiction After Quitting Weed: When One Habit Replaces Another
- Is Weed Addictive? What the Research Actually Shows
- Is Cannabis Addictive? What the DSM-5 and Brain Science Say
- Quitting Weed and Alcohol Together: What to Know About Dual Cessation
- Is Rehab Necessary for Weed? An Honest Assessment
- Signs You May Have Cannabis Use Disorder: An Honest Self-Assessment
- Weed Vape Pen Addiction: Why Vaping Makes It Harder to Quit